Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TICLOPIDINE vs TILDRAKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TICLOPIDINE vs TILDRAKIZUMAB: Safety Overview

Metric TICLOPIDINE TILDRAKIZUMAB
Total FAERS Reports 515 869
Deaths Reported 43 89
Death Rate 8.3% 10.2%
Hospitalizations 324 389
Average Patient Age 76.1 yrs 57.9 yrs
% Female Patients 47.2% 42.5%
FDA Approval Date Apr 26, 2000 N/A
Manufacturer N/A Sun Pharmaceutical Industries, Inc.
Route N/A SUBCUTANEOUS
Marketing Status Discontinued N/A